Perspectives in Psychopharmacology

Anderson KN, Lind JN, Simeone RM, et al.: Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry 2020; e202453Google Scholar

Cuijpers P, Noma H, Karyotaki E, et al.: A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry 2020; 19:92–107Crossref, Google Scholar

Fagiolini A, Alcalá JÁ, Aubel T, et al.: Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel. Ann Gen Psychiatry 2020; 19:55Crossref, Google Scholar

Faraone SV, Rostain AL, Montano CB, et al.: Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies. J Am Acad Child Adolesc Psychiatry 2020; 59:100–112Crossref, Google Scholar

Forester BP, Parikh SV, Weisenbach S, et al.: Combinatorial pharmacogenomic testing improves outcomes for older adults with depression. Am J Geriatr Psychiatry 2020; 28:933–945Crossref, Google Scholar

Gerhard T, Stroup TS, Correll CU, et al.: Mortality risk of antipsychotic augmentation for adult depression. PLoS One 2020; 15:e0239206Crossref, Google Scholar

Jiang WL, Cai DB, Yin F, et al.: Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials. Transl Psychiatry 2020; 10:117Crossref, Google Scholar

Kim N, McCarthy DE, Piper ME, et al.: Comparative effects of varenicline or combination nicotine replacement therapy versus patch monotherapy on candidate mediators of early abstinence in a smoking cessation attempt. Addiction (ahead of print, Sept 4, 2020). doi: 10.1111/add.15248Google Scholar

Leone FT, Zhang Y, Evers-Casey S, et al.: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 202:e5–e31Crossref, Google Scholar

Rakofsky JJ, Talbot TB, Dunlop BW: A virtual standardized patient-based assessment tool to evaluate psychiatric residents’ psychopharmacology proficiency. Acad Psychiatry 2020; 44:693–700Crossref, Google Scholar

Reiff CM, Richman EE, Nemeroff CB, et al.: Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry 2020; 177:391–410Crossref, Google Scholar

Solmi M, Fornaro M, Ostinelli EG, et al.: Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 2020; 19:214–232Crossref, Google Scholar

Yoshida K, Müller DJ: Pharmacogenetics of antipsychotic drug treatment: update and clinical implications. Mol Neuropsychiatry 2020; 5(Suppl 1):1–26Crossref, Google Scholar

Chang Z, Ghirardi L, Quinn PD, et al.: Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry 2019; 86:335–343Crossref, Google Scholar

Corponi F, Fabbri C, Bitter I, et al.: Novel antipsychotics specificity profile: a clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. Eur Neuropsychopharmacol 2019; 29:971–985Crossref, Google Scholar

Earley W, Burgess MV, Rekeda L, et al.: Cariprazine treatment of bipolar depression: a randomized double-blind placebo-controlled phase 3 study. Am J Psychiatry 2019; 176:439–448Crossref, Google Scholar

Factor SA, Burkhard PR, Caroff S, et al.: Recent developments in drug-induced movement disorders: a mixed picture. Lancet Neurol 2019; 18:880–890Crossref, Google Scholar

Furukawa TA, Cipriani A, Cowen PJ, et al.: Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 2019; 6:601–609Crossref, Google Scholar

Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al.: Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019; 394:939–951Crossref, Google Scholar

Kingsberg SA, Clayton AH, Portman D, et al.: Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol 2019; 134:899–908Crossref, Google Scholar

Pardis P, Remington G, Panda R, et al.: Clozapine and tardive dyskinesia in patients with schizophrenia: a systematic review. J Psychopharmacol 2019; 33:1187–1198Crossref, Google Scholar

Vancampfort D, Firth J, Correll CU, et al.: The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019; 18:53–66Crossref, Google Scholar

Waxmonsky JG, Pelham WE III, Campa A, et al.: A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants. J Am Acad Child Adolesc Psychiatry 2020; 59:1330–1341Crossref, Google Scholar

Wolraich ML, Hagan JF Jr, Allan C, et al.: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019; 144:e20192528Crossref, Google Scholar

Clayton AH, Goldstein I, Kim NN, et al.: The International Society for the Study of Women’s Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc 2018; 93:467–487Crossref, Google Scholar

Cortese S, Adamo N, Del Giovane C, et al.: Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018; 5:727–738Crossref, Google Scholar

Mentzel TQ, van der Snoek R, Lieverse R, et al.: Clozapine monotherapy as a treatment for antipsychotic-induced tardive dyskinesia: a meta-analysis. J Clin Psychiatry 2018; 79:17r11852Crossref, Google Scholar

Solmi M, Pigato G, Kane JM, et al.: Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 2018; 12:1215–1238Crossref, Google Scholar

Walshaw PD, Gyulai L, Bauer M, et al.: Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: a double-blind placebo-controlled trial of levothyroxine (L-T₄) and triiodothyronine (T₃). Bipolar Disord 2018; 20:594–603Crossref, Google Scholar

Carbon M, Hsieh CH, Kane JM, et al.: Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry 2017; 78:e264–e278Crossref, Google Scholar

Fernandez HH, Factor SA, Hauser RA, et al.: Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study. Neurology 2017; 88:2003–2010Crossref, Google Scholar

Hauser RA, Factor SA, Marder SR, et al.: KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry 2017; 174:476–484Crossref, Google Scholar

Kanes S, Colquhoun H, Gunduz-Bruce H, et al.: Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 2017; 390:480–489Crossref, Google Scholar

Liu B, Zhang Y, Fang H, et al.: Efficacy and safety of long-term antidepressant treatment for bipolar disorders: a meta-analysis of randomized controlled trials. J Affect Disord 2017; 223:41–48Crossref, Google Scholar

McGirr A, Vöhringer PA, Ghaemi SN, et al.: Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry 2016; 3:1138–1146Crossref, Google Scholar